Back to Stakeholders

The Center for Psychedelic Medicine at NYU Langone Health is directed by Dr. Michael Bogenschutz and performs health-focused research across the translational spectrum, from basic science to large-phase clinical trials. The center has three transdisciplinary areas of focus: psychiatry, medicine, and preclinical research. Currently, the team is actively investigating clinical applications for various psychedelic compounds, leading robust studies on psilocybin-assisted therapy for alcohol use disorder, major depression, and advanced cancer-related psychiatric distress.

Academic Research

1 papers

Published Papers

1

Trial Involvement

2

Distinct Focus Topics

0

Latest Publication

Feb 5, 2026

Quick Facts

Type
academic
HQ
United States
Website
Visit

Collaborated Trials

2

Research Papers

1